Although the role of CD44v in tumor biology requires further investigation, it may be assumed that up-regulation of CD44v4, v5, and v7 is crucial to SFN’s slowing proliferative activity in the prostate cancer cells examined in the present study. This evidence concerns the gene CD101 and prostate cancer.